Results 21 to 30 of about 30,479 (205)
FibroScan compared to liver biopsy for accurately staging recurrent hepatic steatosis and fibrosis after transplantation for MASH. [PDF]
Abstract Background and Aims Metabolic dysfunction‐associated steatotic liver disease (MASLD) recurrence after liver transplantation (LT) seems unavoidable and gradual. We aimed to evaluate the diagnostic accuracy in the post‐LT setting of patients transplanted for metabolic dysfunction‐associated steatohepatitis (MASH) of recurrent hepatic steatosis ...
Martínez-Arenas L +9 more
europepmc +2 more sources
Patients with extensive liver tumour load and a mainly poorly differentiated N2 primary tumour have short overall survival from the time of liver transplantation. Relapses were mostly unresectable and the patients had short survival from the time of relapse. These patients should not be offered liver transplantation.
T. M. Smedman +5 more
wiley +1 more source
Síndrome del linfocito pasajero por anticuerpos anti-D en trasplante hepático. Reporte de caso
El síndrome del linfocito pasajero (PLS) es una complicación de injerto contra huésped que se presenta en el trasplante de órganos sólidos o en el trasplante de células progenitoras hematopoyéticas. Es una causa importante de hemólisis inmune después del
Antonio José Paredes Fernández +2 more
semanticscholar +1 more source
Introducción. El acceso al trasplante hepático (TH) en pacientes con carcinoma hepatocelular (CHC) se basa en la aplicación de criterios morfológicos rigurosos estipulados desde 1996, conocidos como criterios de Milán.
Juan Ignacio Marín-Zuluaga +10 more
semanticscholar +1 more source
Introducción. La asociación entre SARS-CoV-2 y hepatopatías crónicas ha sido descrita mundialmente con cohortes que reportan hasta un 11 % de pacientes hospitalizados con cirrosis hepática o trasplante hepático. Datos publicados reportan un aumento de la
Kevin Navarro-Beleño +4 more
semanticscholar +1 more source
Trasplante hepático en hepatitis alcohólica aguda: ¿debemos decir que no?
Alcohol liver disease is one of the main indications for liver transplantation (LT). Currently, an abstinence period
E. F. Rodríguez-Aguilar +7 more
semanticscholar +1 more source
Valoración preanestésica para trasplante hepático ortotópico.
Orthotopic liver transplantation is one of the greatest challenges faced by the anesthesiologist, therefore, the importance of a correct pre-anesthetic assessment, in order to bring the patient to the most optimal level possible, based on the clinical ...
Diego Escarramán Martínez +8 more
semanticscholar +1 more source
UEG Week 2021 Poster Presentations
United European Gastroenterology Journal, Volume 9, Issue S8, Page 262-907, October 2021.
wiley +1 more source
Serie de casos de trasplante hepático ortotópico del Hospital “Dr. Rafael Ángel Calderón Guardia”
Objetivo: analizar los resultados y evolución del programa de trasplante hepático del Hospital “Dr. Rafael Ángel Calderón Guardia”, así como las complicaciones más frecuentes y características de las hepatopatías que llevaron a trasplante hepático ...
Claudia Catarinella Gómez +5 more
semanticscholar +1 more source
Expression of LAIR‐1 (CD305) on Human Blood Monocytes as a Marker of Hepatic Cirrhosis Progression
Background and Aim. The presumed role of the inhibitory receptor LAIR‐1 (CD305) in the inflammatory response suggests that it might contribute to the pathophysiology of chronic inflammatory diseases such as liver cirrhosis. We studied the LAIR‐1 expression on liver macrophages and blood monocytes related to the progression of liver cirrhosis.
María Martínez-Esparza +10 more
wiley +1 more source

